Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2003

Nov 4, 2003

34519_dirs_2003-11-04_37b04ffc-fb13-4116-9624-9906d7c3f507.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2003-10-31

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2003-10-31 Common Stock, par value $0.10 per share P 500 $3.01 Acquired 345460 Direct
2003-11-03 Common Stock, par value $0.10 per share P 300 $3.06 Acquired 345760 Direct
2003-11-04 Common Stock, par value $0.10 per share P 500 $3.02 Acquired 346260 Direct
2003-11-04 Common Stock, par value $0.10 per share P 500 $3.01 Acquired 346760 Direct

Footnotes

F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.